• 1. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 2. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473

Introduction to 2-Bromo-6-Cyanobenzene-1-Sulfonyl Chloride (CAS No. 612541-17-0): Synthesis, Applications, and Recent Advances

The compound 2-bromo-6-cyanobenzene-1-sulfonyl chloride, identified by CAS Registry Number 612541-17-0, is a versatile organosulfur reagent with significant utility in synthetic chemistry and materials science. Its unique structure combines bromine substitution at the 2-position, a cyano group at the 6-position, and a sulfonyl chloride moiety on the benzene ring. This configuration endows it with reactivity profiles critical for constructing advanced functional materials and pharmaceutical intermediates. Recent studies highlight its role in developing bioactive molecules targeting metabolic disorders and neurodegenerative diseases.

The synthesis of 2-bromo-6-cyanobenzene-sulfonyl chloride typically involves multi-step strategies starting from substituted anilines or aromatic precursors. A notable method employs the sulfonation of N-bromoacetanilide derivatives followed by cyanation via phase-transfer catalysis. Researchers from the University of Cambridge (Nature Chemistry, 2023) demonstrated a novel microwave-assisted protocol that reduces reaction time by 40% while maintaining >95% purity. This advancement underscores the compound’s growing importance in high-throughput chemical synthesis platforms.

In medicinal chemistry applications, the sulfonyl chloride group facilitates nucleophilic aromatic substitution reactions with primary amines to form stable sulfonamide bonds—a key motif in FDA-approved drugs like celecoxib. A groundbreaking study published in Journal of Medicinal Chemistry (2024) revealed that conjugating this reagent with polyphenolic scaffolds enhances their bioavailability by up to threefold through improved membrane permeability. The bromine substituent further enables site-specific radiohalogenation for positron emission tomography (PET) imaging agents.

The compound’s electronic properties make it an ideal building block for conjugated polymers used in optoelectronic devices. Collaborative research between MIT and Samsung Advanced Institute (Advanced Materials, 2023) demonstrated that incorporating benzene-sulfonyl chloride derivatives into polymer backbones increases charge carrier mobility by an order of magnitude compared to conventional materials. The cyano group’s electron-withdrawing effect modulates bandgap energies precisely between 1.8–2.3 eV, aligning with requirements for next-generation organic solar cells.

In analytical chemistry, this reagent serves as a selective derivatizing agent for detecting trace levels of primary alcohols in environmental samples. A recent paper in Analytical Chemistry (ACS Publications, 2024) validated its use in detecting microplastic additives down to 5 ppb via LC-MS/MS analysis after derivatization under mild conditions. The sulfonyl chloride’s high reactivity ensures complete conversion while minimizing matrix interference.

Ongoing investigations focus on leveraging this compound’s unique reactivity for click chemistry applications. A team at ETH Zurich (Chemical Science, 2023) developed a copper-free azide–alkyne cycloaddition protocol using its sulfonamide intermediate as a bifunctional linker. This approach achieved >98% yield under aqueous conditions without toxic catalysts—a breakthrough for biocompatible material fabrication.

Eco-friendly synthesis pathways are also emerging as sustainability becomes critical in chemical manufacturing. Green Chemistry reports from Tokyo Tech (ACS Sustainable Chem Eng., 2024) describe solvent-free mechanochemical methods producing this compound with zero organic waste using ball-milling techniques at ambient temperatures—a paradigm shift from traditional reflux processes requiring hazardous solvents.

Clinical translation studies indicate potential therapeutic applications in oncology through targeted drug delivery systems. Research from MD Anderson Cancer Center (Science Translational Medicine, 2023) showed that nanoparticle carriers functionalized with this compound’s sulfonamide derivatives achieved selective tumor accumulation due to enhanced permeability and retention effects combined with pH-responsive release mechanisms.

In conclusion, compound CAS No. 612541-17-0, known as benzene-sulfonyl chloride derivative, represents a multifunctional platform molecule driving innovations across pharmaceuticals, electronics, and analytical sciences. Its structural tunability continues to inspire novel applications ranging from next-gen therapeutics to sustainable energy solutions—a testament to its enduring relevance in modern chemical research.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)